Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024

AccesswireNov 1 11:55 ET

Matinas MTNB Negotiations Terminated; Biofrontera BFRI Phase 3 Data

BioPharmCatalystOct 31 15:50 ET

Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.

BenzingaOct 31 12:14 ET

Biofrontera Shares Halted On Circuit Breaker To The Upside, Stock Now Up 6.01%

BenzingaOct 31 10:34 ET

Express News | Biofrontera Inc: Primary and Secondary Endpoints All Highly Statistically Significant

ReutersOct 31 10:32 ET

Express News | Biofrontera Inc - Ameluz-Pdt Achieved 65.5% Success Compared to 4.8% With Placebo

ReutersOct 31 10:32 ET